Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > USD$5 million is just initial payment in the contract.
View:
Post by GoldenJJ on Jun 19, 2021 8:38pm

USD$5 million is just initial payment in the contract.

It says the milestone payment will be increased if ryplazim is approved by FDA https://app.quotemedia.com/data/downloadFiling?webmasterId=101442&ref=115890350&type=HTML&symbol=LMNL&companyName=Liminal+BioSciences+Inc.&formType=6-K&formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&dateFiled=2021-05-21&CK=1351172
Comment by GoldenJJ on Jun 19, 2021 8:47pm
Any guess how much value of Ryplazim will be? Maybe a lot than you expect. Let's wait and see the final deal
Comment by GunnerG on Jun 20, 2021 9:18pm
GoldenJJ, it says ; "(b) In the event the BLA and/or the PRV is issued [***], subsequent to Kedrion exercising its Call Option, the amount of the Milestone Payment shall be increased to an amount equal to [***]." BLA and PRV were issued prior to Kedrion exercising, not subsequent.
Comment by GoldenJJ on Jun 20, 2021 10:07pm
Ryplazim business will be sold $5 millions + milestone payment. Even Ryplazim is not approved. Because Ryplazim is approved, the milestone will be much higher than original milestone payment.
Comment by GunnerG on Jun 21, 2021 9:46am
StupsNewcamo, did you get a new ID.  ROF
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities